Over the Counter (OTC) Drugs Market Will Exceed US$ 294.18 Billion By 2030

In 2022, the over the counter (OTC) drugs market study by Precedence Research provides crucial information on market share, market size, growth rate analysis Y-O-Y, production, consumption, and sales analysis for the forecast period 2021 to 2030. The report contains 150+ pages with detailed analysis.

The global over the counter (OTC) drugs market size is forecasted to reach from US$ 160.75 billion in 2021 to US$ 294.18 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 6.9% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The over the counter (OTC) drugs market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1466

The non-prescription medicines are sometimes known as over the counter (OTC) drugs because they are available without a prescription. If taken as directed by a healthcare practitioner, over the counter (OTC) drugs are safe. The growth in awareness of general health problems, as well as innovations in the healthcare and pharmaceutical industries, is driving the growth of over the counter (OTC) drugs market. In addition, an increasing trend among individuals to use over the counter (OTC) drugs for mild ailments contributes towards the growth of over the counter (OTC) drugs market during the forecast period.

cope of the Over the Counter (OTC) Drugs Market

Report Coverage Details
Market Size In 2021 US$ 160.75 Billion
Growth Rate CAGR of 6.9% from 2021 to 2030
Revenue Projection by 2030 US$ 294.18 Billion
Largest Market North America
Fastest Growing Market Asia Pacific

Competitive Intelligence

The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.

Some of the prominent players in the global over the counter (OTC) drugs market are listed as below:

Market Dynamics

Drivers – Growing geriatric population

The population of old or senior people are growing on a large scale. According to World Health Organization (WHO), the number of people of age 65 years or above is expected to grow around 1.5 billion in 2050. The number is expected to rise in developing countries such as China, Japan, India, and South Korea. The geriatric population faces various kinds of health problems such as cancer, diabetes, high blood pressure, and blood sugar levels. They need to be more careful with their health. So, they require medicines at certain interval of time. Sometimes, the geriatric people buy medicines without any kind of prescription. As a result, the growing geriatric population is driving the growth of over the counter (OTC) drugs market during the forecast period.

Restraints – Threat to life of people

The over the counter (OTC) drugs are non-prescribed medicines. The people who have little knowledge about drugs and medicines, consume medicines without consulting doctor or healthcare professional. This can have ill-effects on the health of consumers. The consequences of this action can also have threat on the drug stores and pharmacies. Many incidences have been noticed where people have died by consuming wrong drugs or medicines. To avoid such situations, the over the counter (OTC) drugs need to be banned. Thus, the threat to life of people is a restricting factor for the growth of the over the counter (OTC) drugs market during the forecast period.

Opportunities – Rising awareness of general health problems

After COVID-19 pandemic, the people are more concerned towards their health. The consumption patterns have changed due to coronavirus outbreak. This has created new growth opportunities for the over the counter (OTC) drugs in the market. Before a decade, the people were not aware about the causes of cold and cough. But after the pandemic the people have understood the importance of good health. Many of the consumers have knowledge of medicines that can be consumed during certain health issues. As a result, the rising awareness of general health problems is paving the way for the growth of over the counter (OTC) drugs market during the forecast period.

Challenges – Stringent government regulations

The sale of over the counter (OTC) drugs in some regions is not legal. For this, certain rules and laws need to be followed. The Food and Drug Administration (FDA) has enacted certain regulatory framework that prohibits the use of over the counter (OTC) drugs in the market. In many developed countries, the sale of over the counter (OTC) drugs is banned. As a result, the stringent government regulations are a huge challenge for the growth of over the counter (OTC) drugs market during the forecast period.

Report Highlights

Regional Snapshot

North America is the largest segment for over the counter (OTC) drugs market in terms of region. The change in consumer lifestyle and growing preference of consumers towards over the counter (OTC) drugs is expected to drive the growth of over the counter (OTC) drugs market during the forecast period.

Europe region is the fastest growing region in the over the counter (OTC) drugs market. Europe has large number of over the counter (OTC) drugs manufacturers. This fact is resulting Europe region as one of the dominants in the over the counter (OTC) drugs market.

Segments Covered in the Report

By Product Type

By Distribution Channel

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global over the counter (OTC) drugs market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for over the counter (OTC) drugs are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Buy Full Research Report, Click Here@ https://www.precedenceresearch.com/checkout/1466

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Over the Counter (OTC) Drugs Market 

5.1. COVID-19 Landscape: Over the Counter (OTC) Drugs Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Over the Counter (OTC) Drugs Market, By Product

8.1. Over the Counter (OTC) Drugs Market, by Product Type, 2021-2030

8.1.1. Analgesics

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Cold & Cough Remedies

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Digestives & Intestinal Remedies

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Skin Treatment

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Over the Counter (OTC) Drugs Market, By Distribution Channel

9.1. Over the Counter (OTC) Drugs Market, by Distribution Channel, 2021-2030

9.1.1. Drug Stores & Retail Pharmacies

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Hospital Pharmacies

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Over the Counter (OTC) Drugs Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.3.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2019-2030)

Chapter 11. Company Profiles

11.1. Bayer AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Takeda Pharmaceutical Company Ltd.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Pfizer

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Johnson & Johnson Services Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Sanofi S.A.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Reckitt Benckiser Group PLC

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Novartis AG

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Boehringer Ingelheim International GmbH

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. GlaxoSmithKline PLC

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Mylan

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1466

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Exit mobile version